Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AFRM | New | AFFIRM HLDGS INC | $24,870,442 | – | 1,622,338 | – | 88.82% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $2,629,330 | – | 407,017 | – | 9.39% | – |
| OPEN | New | OPENDOOR TECHNOLOGIES INC | $502,500 | – | 125,000 | – | 1.79% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OPEN | Exit | OPENDOOR TECHNOLOGIES INC | $0 | – | -125,000 | – | -1.11% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -407,017 | – | -11.55% | – |
| AFRM | Exit | AFFIRM HLDGS INC | $0 | – | -1,622,338 | – | -87.34% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AFRM | New | AFFIRM HLDGS INC | $29,299,000 | – | 1,622,338 | – | 85.62% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $4,334,000 | – | 407,017 | – | 12.66% | – |
| OPEN | New | OPENDOOR TECHNOLOGIES INC | $588,000 | – | 125,000 | – | 1.72% | – |